Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

A case of bizarre posttransplant anti-glomerular basement membrane disease.

Olewicz-Gawlik A, Żeromski J, Świerczewska M, Idasiak-Piechocka I, Pawlik M, Sikorska D, Samara H, Oko A, Sikora J, Dworacki G.

Cent Eur J Immunol. 2019;44(2):210-213. doi: 10.5114/ceji.2019.87074. Epub 2019 Jul 30.

2.

Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell Lines.

Sterzyńska K, Kaźmierczak D, Klejewski A, Świerczewska M, Wojtowicz K, Nowacka M, Brązert J, Nowicki M, Januchowski R.

Int J Mol Sci. 2019 Aug 13;20(16). pii: E3927. doi: 10.3390/ijms20163927.

3.

Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays.

Budna-Tukan J, Świerczewska M, Mazel M, Cieślikowski WA, Ida A, Jankowiak A, Antczak A, Nowicki M, Pantel K, Azria D, Zabel M, Alix-Panabières C.

Cancers (Basel). 2019 Jun 10;11(6). pii: E802. doi: 10.3390/cancers11060802.

4.

PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations.

Świerczewska M, Sterzyńska K, Wojtowicz K, Kaźmierczak D, Iżycki D, Nowicki M, Zabel M, Januchowski R.

Int J Mol Sci. 2019 Apr 25;20(8). pii: E2053. doi: 10.3390/ijms20082053.

5.

Mutual Expression of ALDH1A1, LOX, and Collagens in Ovarian Cancer Cell Lines as Combined CSCs- and ECM-Related Models of Drug Resistance Development.

Sterzyńska K, Klejewski A, Wojtowicz K, Świerczewska M, Nowacka M, Kaźmierczak D, Andrzejewska M, Rusek D, Brązert M, Brązert J, Nowicki M, Januchowski R.

Int J Mol Sci. 2018 Dec 23;20(1). pii: E54. doi: 10.3390/ijms20010054.

6.

Myotilin, a New Topotecan Resistant Protein in Ovarian Cancer Cell Lines.

Sterzyńska K, Klejewski A, Wojtowicz K, Świerczewska M, Nowicki M, Brązert J, Januchowski R.

J Cancer. 2018 Oct 22;9(23):4413-4421. doi: 10.7150/jca.27342. eCollection 2018.

7.

The Role of Matrix Gla Protein (MGP) Expression in Paclitaxel and Topotecan Resistant Ovarian Cancer Cell Lines.

Sterzyńska K, Klejewski A, Wojtowicz K, Świerczewska M, Andrzejewska M, Rusek D, Sobkowski M, Kędzia W, Brązert J, Nowicki M, Januchowski R.

Int J Mol Sci. 2018 Sep 25;19(10). pii: E2901. doi: 10.3390/ijms19102901.

8.

New and Old Genes Associated with Primary and Established Responses to Paclitaxel Treatment in Ovarian Cancer Cell Lines.

Świerczewska M, Klejewski A, Brązert M, Kaźmierczak D, Iżycki D, Nowicki M, Zabel M, Januchowski R.

Molecules. 2018 Apr 12;23(4). pii: E891. doi: 10.3390/molecules23040891.

9.

Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients.

Markou A, Lazaridou M, Paraskevopoulos P, Chen S, Świerczewska M, Budna J, Kuske A, Gorges TM, Joosse SA, Kroneis T, Zabel M, Sedlmayr P, Alix-Panabières C, Pantel K, Lianidou ES.

Clin Chem. 2018 Feb;64(2):297-306. doi: 10.1373/clinchem.2017.275503. Epub 2017 Nov 9.

10.

The significance of lumican expression in ovarian cancer drug-resistant cell lines.

Klejewski A, Sterzyńska K, Wojtowicz K, Świerczewska M, Partyka M, Brązert M, Nowicki M, Zabel M, Januchowski R.

Oncotarget. 2017 Aug 10;8(43):74466-74478. doi: 10.18632/oncotarget.20169. eCollection 2017 Sep 26.

11.

New and Old Genes Associated with Primary and Established Responses to Cisplatin and Topotecan Treatment in Ovarian Cancer Cell Lines.

Świerczewska M, Klejewski A, Wojtowicz K, Brązert M, Iżycki D, Nowicki M, Zabel M, Januchowski R.

Molecules. 2017 Oct 13;22(10). pii: E1717. doi: 10.3390/molecules22101717.

12.

Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines.

Januchowski R, Sterzyńska K, Zawierucha P, Ruciński M, Świerczewska M, Partyka M, Bednarek-Rajewska K, Brązert M, Nowicki M, Zabel M, Klejewski A.

Oncotarget. 2017 Jul 25;8(30):49944-49958. doi: 10.18632/oncotarget.18278.

13.

New and Old Genes Associated with Topotecan Resistance Development in Ovarian Cancer Cell Lines.

Klejewski A, Świerczewska M, Zaorska K, Brązert M, Nowicki M, Zabel M, Januchowski R.

Anticancer Res. 2017 Apr;37(4):1625-1636.

PMID:
28373423
14.

Increased Expression of Several Collagen Genes is Associated with Drug Resistance in Ovarian Cancer Cell Lines.

Januchowski R, Świerczewska M, Sterzyńska K, Wojtowicz K, Nowicki M, Zabel M.

J Cancer. 2016 Jun 25;7(10):1295-310. doi: 10.7150/jca.15371. eCollection 2016.

15.

Polymorphic variants of MIF gene and prognosis in steroid therapy in children with idiopathic nephrotic syndrome.

Świerczewska M, Ostalska-Nowicka D, Kempisty B, Szczepankiewicz A, Nowicki M.

Acta Biochim Pol. 2014;61(1):67-75. Epub 2014 Mar 18.

16.

Molecular basis of mechanisms of steroid resistance in children with nephrotic syndrome.

Swierczewska M, Ostalska-Nowicka D, Kempisty B, Nowicki M, Zabel M.

Acta Biochim Pol. 2013;60(3):339-44. Epub 2013 Aug 1. Review.

Supplemental Content

Loading ...
Support Center